Skip to Content

Encevac TC-4 with Havlogen (Canada)

This page contains information on Encevac TC-4 with Havlogen for veterinary use.
The information provided typically includes the following:
  • Encevac TC-4 with Havlogen Indications
  • Warnings and cautions for Encevac TC-4 with Havlogen
  • Direction and dosage information for Encevac TC-4 with Havlogen

Encevac TC-4 with Havlogen

This treatment applies to the following species:
Manufacturer: Merck Animal Health

ENCEPHALOMYELITIS - INFLUENZA VACCINE, EASTERN & WESTERN, KILLED VIRUS, TETANUS TOXOID

A combination of inactivated, concentrated, adjuvanted, tissue culture origin equine encephalomyelitis viruses (Eastern and Western), equine influenza virus type H3N8 strains (EIV A/Equine 2/ Kentucky/93 American, EIV A/Equine 2/Kentucky/02 American and EIV A/Equine 2/Newmarket/2/93 Eurasian) and tetanus toxoid. Intervet serological data suggest influenza cross protection against certain U.S. and European strains, including Kentucky 91, 93, 99, 02, Ohio 03, Newmarket/1/93, Newmarket/2/93, Suffolk 89 and South Africa 03.

Encevac TC-4 with Havlogen Indications

For vaccination of healthy horses 6 months of age or older, as an aid in the prevention of disease caused by Eastern and Western encephalomyelitis viruses and tetanus and as an aid in the control of respiratory disease and as an aid in the reduction of virus shedding caused by EIV. Duration of immunity (DOI) has been shown to be at least 6 months for EIV. Foals nursing immune-dams should be vaccinated when maternal antibody levels will allow active immunization.

DOSE: For primary vaccination aseptically administer 1 mL intramuscularly, repeat with a single dose in 3 - 4 weeks. Annual revaccination is recommended. A booster dose can be administered at more frequent intervals based upon individual horse or farm disease risk assessment or any time epidemic conditions exist or are reported. Consult your veterinarian.

CAUTIONS: Store at 2°-7°C (35°-45°F). Shake well before using. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. Local reaction may occur if this product is given subcutaneously. Inject deep into the muscle only. Anaphylactic reactions may occur. If allergic reaction occurs, treat with epinephrine. Care should be used to avoid injecting your own fingers, hands, or other body parts. Accidental injection can cause serious local reactions. Contact a physician immediately if an accidental injection occurs.

ANTIBIOTIC: Gentamicin.

PRESERVATIVE: Thimerosal.

Adjuvant: Intervet’s Proprietary Technology

FOR ANIMAL USE ONLY

Intervet Inc., Merck Animal Health, division of Intervet Inc., Omaha, NE 68103, USA

U.S. Vet Lic. No 165A

1 800 521-5767 (USA)

1 866 683-7838 (CAN)

For patent information:

http://www.merck.com/product/patent/home.html

 

 

Code

 

10 Doses

10 x 1 mL Syringes

035127

147599-03

10 Doses

10 mL

031685

125901-05

NAC No.: 1208138.3

MERCK ANIMAL HEALTH
Intervet Canada Corp.

16750 ROUTE TRANSCANADIENNE, KIRKLAND, QC, H9H 4M7
Order Desk:   514-428-7013
Toll-Free:   866-683-7838
Fax:   Toll-free 888-498-4444; local 514-428-7014
Website:   www.merck-animal-health.ca
Every effort has been made to ensure the accuracy of the Encevac TC-4 with Havlogen information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.

Copyright © 2015 North American Compendiums. Updated: 2015-07-09

Hide